ReviewClinical and translational medicine2018

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.

Jun Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.